Advanced Prenatal Therapeutics

APT's mission is to develop an effective treatment that will safely prolong pregnancy, allowing babies more time to develop in the womb. APT believes that its innovative device designs and associated trade secrets will provide APT with an enduring competitive edge. Smith has over fifteen years of experience in regulatory affairs and the development of novel technologies from concept through commercialization. Smith has over forty years of experience in the healthcare industry. Thiel has over ten years of experience in the biotechnology industry providing services in business development, fund raising, corporate finance, investor relations, strategic planning, marketing and public relations for early-stage development companies. Jacqueline has over ten years of experience in the biotechnology sector supporting new product development. Jacqueline holds a professional certificate in Medical Product Development and a Bachelor of Science in Biological Sciences with a minor in Business Management from the University of California in Irvine. Anne Garrett, a preeclampsia survivor herself, is a passionate advocate of safe pregnancy in the United States and worldwide.